#37: ZILA Stock News : Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening
SCOTTSDALE, Ariz., May 13 /PRNewswire-FirstCall/ -- At a congressional hearing today in Washington, DC,
legislators were urged to press the U.S. Department of Veterans Affairs
to...
Zila, Inc. (NASDAQ:ZILA) today announced that the company has completed
a 1-for-7 reverse stock split. Accordingly, every seven shares of the
company’s common stock have...
Zila, Inc. (NASDAQ:ZILA) today announced that the U.S. Food and Drug
Administration (FDA) has granted the company 510(k) clearance to market
ViziLite Eyewear. ViziLite Eyewear is...
Zila, Inc. (NASDAQ:ZILA) today announced that its board of directors
named David R. Bethune interim chief executive officer in addition to
his role as chairman. Bethune has been a...
Zila, Inc. (Nasdaq: ZILA) today announced that it will release its
financial results for the fiscal 2008 second quarter ended January 31,
2008, after the market closes on Tuesday,...
- Canadian Launch Set for Toronto Meeting -
Zila, Inc. (NASDAQ:ZILA) today announced that it will begin its global expansion initiative with the distribution of ViziLite® Plus with...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq: ZILA) will release financial results for the fiscal 2007 second quarter ended January 31, 2007, after the market close on Thursday, March...
PHOENIX--(BUSINESS WIRE)--Zila, Inc.’s (Nasdaq GM: ZILA), Chairman,
Chief Executive Officer, and President, Douglas D. Burkett, Ph.D., and
Zila Pharmaceuticals Inc.’s...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq GM: ZILA) announced results for its first quarter of
fiscal 2007 that ended October 31, 2006. With the recent acquisition of
Professional...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq: ZILA) will release financial results for the fiscal
2007 first quarter ended October 31, 2006, at the market close on
Thursday, December...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ GM: ZILA), has completed the acquisition of
Professional Dental Technologies, Inc. (“Pro-Dentec®”)
a privately-held,...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq GM: ZILA) reported today that it has acquired the
rights to manufacture and distribute ViziLite®
in the Pacific Rim from President...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ GM: ZILA), announced the execution of a definitive
agreement for the acquisition of Professional Dental Technologies, Inc....
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ GM: ZILA), announced the execution of definitive
agreements for a private placement of $40 million in common stock,
convertible debt...
PHOENIX--(BUSINESS WIRE)--The Board of Directors of Zila, Inc. (Nasdaq GM: ZILA) elected Dr. David
Sidransky to join its ranks, effective October 24, 2006. Dr. Sidransky
will complete...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ GM: ZILA) reported its financial results for the
fiscal year and fourth quarter ended July 31, 2006.
Fiscal 2006 Financial Results:
--...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq GM: ZILA) will release financial results for the full
year and fourth quarter of its fiscal year ended July 31, 2006, at
market close on...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq GM: ZILA)
has completed the divestiture of its wholly-owned subsidiary Zila
Nutraceuticals, Inc. for a total cash transaction of $37.5...
PHOENIX--(BUSINESS WIRE)--Zila, Inc. (Nasdaq GM: ZILA)
received shareholder approval at a Special Shareholders Meeting held
September 27, 2006 to divest its wholly-owned subsidiary...
PHOENIX--(BUSINESS WIRE)--Aug. 23, 2006--Zila, Inc. (Nasdaq GM: ZILA) filed a Preliminary Proxy Statement after market on August 22, 2006 in preparation for a Special Shareholders Meeting to be...
PHOENIX--(BUSINESS WIRE)--Aug. 14, 2006--Zila, Inc. (Nasdaq GM: ZILA) announced that it has signed a definitive agreement for the sale of all of the common stock of its Zila Nutraceuticals, Inc....
PHOENIX--(BUSINESS WIRE)--July 25, 2006--Zila Inc. (Nasdaq GM: ZILA) has closed on the sale of the assets of its Zila Swab Technologies, Inc. or "IST" subsidiary to Great Midwest Packaging, LLC....
PHOENIX--(BUSINESS WIRE)--July 24, 2006--Pursuant to Zila Inc.'s (Nasdaq GM: ZILA) Employee Stock Purchase Plan, and a Rule 10b5-1 Plan, which was announced December 13, 2005, Douglas D. Burkett,...
PHOENIX--(BUSINESS WIRE)--Dec. 13, 2005--Douglas D. Burkett, PhD, Chairman, Chief Executive Officer, and President of Zila, Inc., (Nasdaq: ZILA), announced that he has established a Rule 10b5-1...
PHOENIX--(BUSINESS WIRE)--Dec. 13, 2005--Zila, Inc., (Nasdaq: ZILA), announced that it has begun its Phase III clinical trial for OraTest, its oral cancer detection drug, with the completion of a...
#11: ZILA News Zila Signs Agreements to Expand Market Coverage for Ester-C(R) Products in the Scandinavian Region; Ensures More Ester-C(R) Products Will Be on the Shelf in Sweden, Denmark and Finland Complementing Existing Strong Distribution in Norway
PHOENIX--(BUSINESS WIRE)--Dec. 12, 2005--Zila, Inc.,(Nasdaq: ZILA), announced that its wholly owned subsidiary, Zila Nutraceuticals, Inc., has signed two separate agreements with Cederroth...
PHOENIX--(BUSINESS WIRE)--Dec. 8, 2005--Zila, Inc. (Nasdaq:ZILA) announced results for its first quarter of fiscal 2006 that ended October 31, 2005. Highlights of those results, compared with the...
PHOENIX--(BUSINESS WIRE)--Dec. 8, 2005--Zila, Inc., (Nasdaq: ZILA), announced today that it has reached agreement with the United States Food and Drug Administration (FDA) on the design and size of...
PHOENIX--(BUSINESS WIRE)--Dec. 5, 2005--Zila, Inc. (Nasdaq: ZILA) will release financial results for the fiscal 2006 first-quarter ended October 31, 2005, at the market close on Thursday, December...
PHOENIX--(BUSINESS WIRE)--Nov. 17, 2005--Zila, Inc., (NASDAQ:ZILA), announced today that its wholly owned subsidiary, Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to...
PHOENIX--(BUSINESS WIRE)--Oct. 20, 2005--Zila, Inc. (Nasdaq:ZILA) today commented on a study conducted for the Australian company, Phosphagenics Limited, that confirms an earlier study suggesting...
PHOENIX--(BUSINESS WIRE)--Oct. 12, 2005--Zila, Inc. (Nasdaq: ZILA) announced its financial results for the quarter and fiscal year ended July 31, 2005. Highlights of those results, compared with...
PHOENIX--(BUSINESS WIRE)--Oct. 6, 2005--Zila, Inc. (Nasdaq: ZILA) will release financial results for the fiscal 2005 fourth-quarter and year ended July 31, 2005, at the market close on Wednesday,...
PHOENIX--(BUSINESS WIRE)--Oct. 5, 2005--Zila Pharmaceuticals, Inc., a business unit of Zila, Inc. (Nasdaq:ZILA), will launch its ViziLite(R) Plus with TBlue630(TM) oral lesion identification and...
PHOENIX--(BUSINESS WIRE)--Sept. 12, 2005--Zila, Inc. (Nasdaq:ZILA) commented on a recent journal article in which the authors address the potential efficacy of toluidine blue in identifying...
PHOENIX--(BUSINESS WIRE)--June 27, 2005--Zila, Inc. (Nasdaq:ZILA) today announced that it has closed on the sale of its Zilactin brand OTC lip and oral care products to Blairex Laboratories, Inc....
